MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1371/journal.pone.0243872

Медицинская библиотека · PloS one · 2020

Fibroblast growth factor 23 and cognitive impairment: The health, aging, and body composition study.

Drew David A, Katz Ronit, Kritchevsky Stephen, Ix Joachim H, Shlipak Michael, Newman Anne B, Hoofnagle Andy, Fried Linda, Gutiérrez Orlando M, Sarnak Mark

СтатьяНаблюдательное исследованиеПоддержка NIH: внешняя программаResearch Support, N.I.H., IntramuralПеревод в очереди

Аннотация

BACKGROUND

Concentrations of fibroblast growth factor 23 (FGF-23), a hormone that regulates phosphorus and vitamin D metabolism, increase as kidney function declines. Excess fibroblast growth factor 23 may impact brain function through promotion of vascular disease or through direct effects on neuronal tissue.

METHODS

In the Healthy Aging and Body Composition Study, a longitudinal observational cohort of well-functioning older adults, intact serum FGF-23 was assayed in 2,738 individuals. Cognitive function was assessed at baseline and longitudinally at years 3, 5, and 8 by administration of the Modified Mini Mental State Examination (3MSE), a test of global cognitive function, and the Digit Symbol Substitution Test (DSST), a test primarily of executive function. The associations between FGF-23 and baseline cognitive function and incident cognitive impairment were evaluated using logistic and Poisson regression respectively, and were adjusted for demographics, baseline estimated glomerular filtration rate (eGFR), urine albumin/creatinine ratio, comorbidity, and other measures of mineral metabolism including soluble klotho.

RESULTS

The mean (SD) age was 74(3) years, with 51% female, and 39% black. The median (25th, 75th) FGF-23 concentration was 47 pg/mL (37, 60). Three hundred ninety-two individuals had prevalent cognitive impairment by the 3MSE and 461 by the DSST. There was no observed association between FGF-23 and baseline cognitive function for either cognitive test. There were 277 persons with incident cognitive impairment by 3MSE, and 333 persons with incident cognitive impairment by DSST. In fully adjusted models, each two-fold higher concentration of baseline FGF-23 was not associated with incident cognitive impairment by the 3MSE (IRR = 1.02[0.88, 1.19] fully adjusted model) or by the DSST (IRR = 0.98 [0.84, 1.15]. We saw no difference when analyses were stratified by eGFR greater than or less than 60 ml/min/1.73m2.

CONCLUSION

Intact FGF-23 was not associated with baseline cognitive function or incident cognitive impairment in this cohort well-functioning older adults.

Для цитирования: Drew David A, Katz Ronit, Kritchevsky Stephen, Ix Joachim H, Shlipak Michael, Newman Anne B, Hoofnagle Andy, Fried Linda, Gutiérrez Orlando M, Sarnak Mark. Fibroblast growth factor 23 and cognitive impairment: The health, aging, and body composition study.. PloS one. 2020. DOI: 10.1371/journal.pone.0243872.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.